Results 261 to 270 of about 4,993,835 (349)

Manual Chapter 3: Seismic sources and source parameters

open access: yes, 2001
P. Bormann   +5 more
openaire   +2 more sources

TS3 System parameters for different cases at which one harmonic source is turned off and the other two are present.

open access: green
Abdallah Aldosary (21370131)   +3 more
openalex   +1 more source

Assessment of Some Anionic Parameters and Organic Components, as Pollution Indicators in Drinking Water Sources in Rural Areas of Abuja “F.C.T”, Nigeria

open access: diamond, 2017
Raphael Odoh   +86 more
openalex   +1 more source

Predicting Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Accurate localization of epileptogenic tubers (ETs) in patients with tuberous sclerosis complex (TSC) is essential but challenging, as these tubers lack distinct pathological or genetic markers to differentiate them from other cortical tubers.
Tinghong Liu   +11 more
wiley   +1 more source

Life‐Threatening Bradycardia in Anti‐NMDA‐Receptor Encephalitis and a Novel Use for Permanent Pacing

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Pediatric anti‐NMDA receptor encephalitis (pNMDARE) is an autoantibody‐mediated disorder that can cause severe autonomic dysfunction, including symptomatic bradycardia and asystole. Dysautonomia can last for years, making it very challenging to manage.
Sarah Tucker   +9 more
wiley   +1 more source

THE STUDY OF GAMMA RADIATION PARAMETERS ON THE COMPUTER MODEL OF THE NEUTRON SOURCE ON THE LINEAR ELECTRON ACCELERATOR

open access: gold
S.P. Gokov   +5 more
openalex   +1 more source

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy